NCT00157729View on ClinicalTrials.gov

MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

July 31, 2005

Conditions
Diabetes Mellitus Type 2HypertensionMetabolic Syndrome
Interventions
DRUG

pyridoxal-5'-phosphate with and without ACE inhibitor

Trial Locations (1)

G1V 4G2

Centre Hospitalier Université Laval, Sainte-Foy

Sponsors

Lead Sponsor

Medicure
All Listed Sponsors
lead

Medicure

INDUSTRY

NCT00157729 - MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics) | Biotech Hunter | Biotech Hunter